NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,125 filers reported holding NOVARTIS A G in Q2 2020. The put-call ratio across all filers is 0.55 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $364,353 | -93.1% | 3,577 | -93.8% | 0.04% | -96.1% |
Q1 2023 | $5,279,696 | +557.5% | 57,388 | +504.1% | 1.10% | +240.6% |
Q2 2022 | $803,000 | -16.1% | 9,499 | -18.8% | 0.32% | +251.1% |
Q3 2021 | $957,000 | -45.9% | 11,701 | -39.7% | 0.09% | -62.9% |
Q2 2021 | $1,770,000 | -24.6% | 19,397 | -28.1% | 0.25% | -51.1% |
Q3 2020 | $2,347,000 | +933.9% | 26,987 | +938.0% | 0.51% | +205.4% |
Q2 2020 | $227,000 | -93.5% | 2,600 | -94.4% | 0.17% | -31.7% |
Q2 2018 | $3,495,000 | +209.3% | 46,266 | +251.4% | 0.24% | +76.1% |
Q3 2017 | $1,130,000 | +302.1% | 13,166 | +291.1% | 0.14% | +245.0% |
Q2 2017 | $281,000 | +87.3% | 3,366 | +62.9% | 0.04% | +33.3% |
Q4 2016 | $150,000 | +87.5% | 2,066 | +113.9% | 0.03% | +11.1% |
Q2 2016 | $80,000 | -13.0% | 966 | -9.4% | 0.03% | -57.1% |
Q4 2015 | $92,000 | -100.0% | 1,066 | -79.5% | 0.06% | -83.2% |
Q3 2014 | $489,476,000 | +270328.7% | 5,200 | +160.0% | 0.38% | +114.3% |
Q2 2014 | $181,000 | +277.1% | 2,000 | +233.3% | 0.18% | +230.2% |
Q4 2013 | $48,000 | – | 600 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
PRENTISS SMITH & CO INC | 127,510 | $11,721,000 | 6.50% |
MANAGED ASSET PORTFOLIOS, LLC | 127,716 | $11,740,000 | 6.04% |
EXENCIAL WEALTH ADVISORS, LLC | 116,917 | $10,747,000 | 5.25% |
MCDANIEL TERRY & CO | 181,095 | $16,646,000 | 4.64% |
Fayerweather Charles | 18,180 | $1,671,000 | 4.54% |
Osher Van de Voorde Investment Management | 78,138 | $7,182,000 | 4.38% |
BROWN BROTHERS HARRIMAN & CO | 9,291,495 | $854,074,000 | 4.35% |
Boulegeris Investments, Inc. | 61,322 | $5,637,000 | 4.31% |
DODGE & COX | 45,723,035 | $4,202,861,000 | 4.23% |
WHV Investments, Inc. | 1,603,476 | $152,945,000 | 4.23% |